Showing 1 - 20 results of 34 for search 'Hargadon, B', query time: 0.05s
Refine Results
-
1
Airway dysfunction and inflammation in pool- and non-pool-based elite athletes. by Martin, N, Lindley, MR, Hargadon, B, Monteiro, W, Pavord, I
Published 2012Journal article -
2
Sputum eosinophilia in idiopathic pulmonary fibrosis. by Birring, S, Parker, D, McKenna, S, Hargadon, B, Brightling, C, Pavord, I, Bradding, P
Published 2005Journal article -
3
COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils by Eltboli, O, Bafadhel, M, Hollins, F, Wright, A, Hargadon, B, Kulkarni, N, Brightling, C
Published 2014Journal article -
4
Lung function decline and variable airway inflammatory pattern: Longitudinal analysis of severe asthma by Newby, C, Agbetile, J, Hargadon, B, Monteiro, W, Green, R, Pavord, I, Brightling, C, Siddiqui, S
Published 2014Journal article -
5
Lung function decline and variable airway inflammatory pattern: longitudinal analysis of severe asthma. by Newby, C, Agbetile, J, Hargadon, B, Monteiro, W, Green, R, Pavord, I, Brightling, C, Siddiqui, S
Published 2014Journal article -
6
Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. by Green, R, Brightling, C, McKenna, S, Hargadon, B, Parker, D, Bradding, P, Wardlaw, A, Pavord, I
Published 2002Journal article -
7
Airway function and markers of airway inflammation in patients with treated hypothyroidism. by Birring, S, Patel, R, Parker, D, McKenna, S, Hargadon, B, Monteiro, W, Falconer Smith, J, Pavord, I
Published 2005Journal article -
8
Observational study of the natural history of eosinophilic bronchitis. by Berry, M, Hargadon, B, McKenna, S, Shaw, D, Green, R, Brightling, C, Wardlaw, A, Pavord, I
Published 2005Journal article -
9
A cross-sectional study of patterns of airway dysfunction, symptoms and morbidity in primary care asthma. by Shaw, D, Green, R, Berry, M, Mellor, S, Hargadon, B, Shelley, M, McKenna, S, Thomas, M, Pavord, I
Published 2012Journal article -
10
Association between neutrophilic airway inflammation and airflow limitation in adults with asthma. by Shaw, D, Berry, M, Hargadon, B, McKenna, S, Shelley, M, Green, R, Brightling, C, Wardlaw, A, Pavord, I
Published 2007Journal article -
11
Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness. by Green, R, Brightling, C, McKenna, S, Hargadon, B, Neale, N, Parker, D, Ruse, C, Hall, I, Pavord, I
Published 2006Journal article -
12
The role of oral methotrexate as a steroid sparing agent in refractory eosinophilic asthma. by Bilocca, D, Hargadon, B, Pavord, I, Green, R, Brightling, C, Bradding, P, Wardlaw, A, Martin, N, Murphy, A, Siddiqui, S
Published 2017Journal article -
13
Exacerbations of severe asthma in patients treated with mepolizumab by Shrimanker, R, Pavord, I, Yancey, S, Heaney, L, Green, R, Bradding, P, Hargadon, B, Brightling, C, Wardlaw, A, Haldar, P
Published 2018Journal article -
14
Body mass and fat mass in refractory asthma: an observational 1 year follow-up study. by Bafadhel, M, Singapuri, A, Terry, S, Hargadon, B, Monteiro, W, Green, R, Bradding, P, Wardlaw, A, Pavord, I, Brightling, C
Published 2010Journal article -
15
Evidence of a role of tumor necrosis factor alpha in refractory asthma. by Berry, M, Hargadon, B, Shelley, M, Parker, D, Shaw, D, Green, R, Bradding, P, Brightling, C, Wardlaw, A, Pavord, I
Published 2006Journal article -
16
Alveolar nitric oxide in adults with asthma: evidence of distal lung inflammation in refractory asthma. by Berry, M, Hargadon, B, Morgan, A, Shelley, M, Richter, J, Shaw, D, Green, R, Brightling, C, Wardlaw, A, Pavord, I
Published 2005Journal article -
17
Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: A 12-month follow-up analysis by Haldar, P, Brightling, C, Singapuri, A, Hargadon, B, Gupta, S, Monteiro, W, Bradding, P, Green, R, Wardlaw, A, Ortega, H, Pavord, I
Published 2014Journal article -
18
Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease. by Brightling, C, McKenna, S, Hargadon, B, Birring, S, Green, R, Siva, R, Berry, M, Parker, D, Monteiro, W, Pavord, I, Bradding, P
Published 2005Journal article -
19
The peripheral blood eosinophil count as a biomarker of eosinophilic airway inflammation in patients with asthma and COPD. Experience from a single centre by Shrimanker, R, Thulborn, S, Mistry, V, Connolly, C, Borg, C, Hargadon, B, Hambleton, K, Hynes, G, Brightling, C, Pavord, I, Bafadhel, M
Published 2017Conference item -
20
Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: a 12-month follow-up analysis. by Haldar, P, Brightling, C, Singapuri, A, Hargadon, B, Gupta, S, Monteiro, W, Bradding, P, Green, R, Wardlaw, A, Ortega, H, Pavord, I
Published 2014Journal article